Literature DB >> 7961124

S100-positive histiocytes in T-cell-dependent area in human lymph nodes express P-glycoprotein.

K Nishii1, K Kita, H Miwa, T Ohno, M Yamaguchi, K Oka, S Shirakawa, M Fukumoto.   

Abstract

In the present study, we examined P-glycoprotein (P-gp)-expressing cells in human lymph nodes (LN) from patients with reactive lymph adenitis and various malignant lymphomas (ML). MDR1 mRNA was detected in all reactive LN and in 8 of 10 ML samples examined by reverse transcription polymerase chain reaction (RT-PCR). The signal intensity of the bands was stronger in samples from T-cell ML LN than in those from LN of reactive lymph adenitis and B-cell ML. Immunohistochemistry also showed positive reactivity with cellular components in the LN. The P-gp-positive cells, detected by UIC2, in reactive lymph adenitis and ML samples were large in size in the T-cell-dependent paracortical area in LN. Further, morphological characteristics were similar in UIC2-positive cells between reactive and ML LN. Double staining with UIC2 and a hematopoietic cell lineage-specific monoclonal antibody showed that UIC2-positive cell co-expressed S-100, but not other lymphocyte- and ML cell-specific antigens, indicating that these cells correspond to histiocytes in the T-cell-dependent paracortical area. Our results show that P-gp was expressed in histiocytes but not ML cells in LN, and suggest that this molecule may play an important role in the biological function of histiocytes and/or for maintenance of homeostatic levels in T-cell ML LN.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7961124      PMCID: PMC5919583          DOI: 10.1111/j.1349-7006.1994.tb02973.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  24 in total

1.  Functional role for the 170- to 180-kDa glycoprotein specific to drug-resistant tumor cells as revealed by monoclonal antibodies.

Authors:  H Hamada; T Tsuruo
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

2.  Tissue distribution of P-glycoprotein encoded by a multidrug-resistant gene as revealed by a monoclonal antibody, MRK 16.

Authors:  I Sugawara; I Kataoka; Y Morishita; H Hamada; T Tsuruo; S Itoyama; S Mori
Journal:  Cancer Res       Date:  1988-04-01       Impact factor: 12.701

3.  P-glycoprotein expression in malignant lymphoma and reversal of clinical drug resistance with chemotherapy plus high-dose verapamil.

Authors:  T P Miller; T M Grogan; W S Dalton; C M Spier; R J Scheper; S E Salmon
Journal:  J Clin Oncol       Date:  1991-01       Impact factor: 44.544

4.  Purification of P-glycoprotein from plasma membrane vesicles of Chinese hamster ovary cell mutants with reduced colchicine permeability.

Authors:  J R Riordan; V Ling
Journal:  J Biol Chem       Date:  1979-12-25       Impact factor: 5.157

5.  Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells.

Authors:  P M Chaudhary; I B Roninson
Journal:  Cell       Date:  1991-07-12       Impact factor: 41.582

6.  Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy.

Authors:  W S Dalton; T M Grogan; P S Meltzer; R J Scheper; B G Durie; C W Taylor; T P Miller; S E Salmon
Journal:  J Clin Oncol       Date:  1989-04       Impact factor: 44.544

7.  Expression of a multidrug resistance gene in human cancers.

Authors:  L J Goldstein; H Galski; A Fojo; M Willingham; S L Lai; A Gazdar; R Pirker; A Green; W Crist; G M Brodeur
Journal:  J Natl Cancer Inst       Date:  1989-01-18       Impact factor: 13.506

8.  Immunohistochemical identification of P-glycoprotein in previously untreated, diffuse large cell and immunoblastic lymphomas.

Authors:  G A Niehans; W Jaszcz; V Brunetto; R T Perri; K Gajl-Peczalska; M R Wick; T Tsuruo; C D Bloomfield
Journal:  Cancer Res       Date:  1992-07-01       Impact factor: 12.701

9.  Immunohistochemical distribution of S-100 protein in tumors and tumor-like lesions of bone and cartilage.

Authors:  K Okajima; I Honda; T Kitagawa
Journal:  Cancer       Date:  1988-02-15       Impact factor: 6.860

Review 10.  The role of the MDR1 (P-glycoprotein) gene in multidrug resistance in vitro and in vivo.

Authors:  I B Roninson
Journal:  Biochem Pharmacol       Date:  1992-01-09       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.